Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2019 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Triplet (FOLFOXIRI) versus doublet (FOLFOX or FOLFIRI) backbone chemotherapy as first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysis.
Crit Rev Oncol Hematol. 2017 Oct;118:54-62. doi: 10.1016/j.critrevonc.2017.08.006. Epub 2017 Aug 25.
Crit Rev Oncol Hematol. 2017.
PMID: 28917269
Review.
Cetuximab versus bevacizumab in metastatic colorectal cancer: a comparative effectiveness study.
Marques RP, Godinho AR, Heudtlass P, Pais HL, Quintela A, Martins AP.
Marques RP, et al.
J Cancer Res Clin Oncol. 2020 May;146(5):1321-1334. doi: 10.1007/s00432-020-03167-0. Epub 2020 Mar 6.
J Cancer Res Clin Oncol. 2020.
PMID: 32144533
Item in Clipboard
Patient-reported outcomes and health-related quality of life for cetuximab versus bevacizumab in metastatic colorectal cancer: a prospective cohort study.
Marques RP, Heudtlass P, Pais HL, Quintela A, Martins AP.
Marques RP, et al.
J Cancer Res Clin Oncol. 2019 Jul;145(7):1719-1728. doi: 10.1007/s00432-019-02924-0. Epub 2019 Apr 29.
J Cancer Res Clin Oncol. 2019.
PMID: 31037398
Item in Clipboard
Cite
Cite